MindMaze Home Rehab Data Shows 3x Training Dose Before Lite Launch
Geneva – October 14, 2026 -- MindMaze Therapeutics (SIX: MMTX) reported that home-based rehabilitation with its MindMotion platform raised total motor-training dose by a median factor of 3.0 versus usual outpatient therapy alone, with 84% of active training completed without direct therapist supervision.
The multi-site program, run with Vibra Healthcare, was presented at the American Congress of Rehabilitation Medicine (ACRM) in Washington, DC. The data arrive ahead of the company's MindMotion Lite launch, expected by year-end 2026.
Program covered 177 episodes across four Vibra outpatient sites
The retrospective quality improvement program evaluated 177 rehabilitation episodes involving 172 adults with neurological conditions, primarily stroke. It had no control group. Participants followed an eight-week home-training program using MindMotion GO, with an optional four-week extension and periodic therapist supervision.